Mylotarg, a new antibody-drug conjugate, ADC, approved by the FDA for treatment of acute myeloid leukemia
Maryland, USA, Friday, September 1, 2017 - The U.S. Food and Drug Administration approved the ADC Mylotarg, gemtuzumab ozogamicin, for the treatment of adults with newly diagnosed acute myeloid leukemia, [...]